CD4+CD25+Foxp3+ Treg and TGF-β play important roles in pathogenesis of Uygur cervical carcinoma

European Journal of Gynaecological Oncology

Volumn 33, Issue 5, 2012, Pages 502-507

  Chen, Z F ^a,b   Xu, Q ^b   Ding, J B ^b   Zhang, Y ^a   Du, R ^b   Ding, Y ^b  

^a Central South University   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

CD4+CD25+Foxp3+ Treg; Cervical carcinoma; TGF ; Uygur

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CANCER SURGERY; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CHINA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UTERINE CERVICAL NEOPLASMS;

EID: 84868602380     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Parkin D.M., Bray F.: "The burden of HPV-related carcinomas". Vaccine, 2006, 24 (suppl. 3), S11.
2. Pacholska-Bogalska J., Józefiak A., Nowak W. et al.: "Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer". Eur. J. Gynaecol. Oncol., 2011, 32, 393.
3. Barbisan G., Pérez L.O., Difranza L. et al.: "XRCC1 Arg399G1n polymorphism and risk for cervical cancer development in Argentine women". Eur. J. Gynaecol. Oncol., 2011, 32, 274.
4. Christian M., Dela G.: "CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use". Swiss Med. Wkly, 2007, 137, 625.
5. Bor-Ching S., Wen-Chun C., Ho-Hsiung L., Song-Nan C., SuCheng H.: "Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia". J. Obstet. Gynaecol., 2007, 33, 103.
6. Wang R.F.: "Regulatory T cells and innate immune regulation in tumor immunity". Springer Semin. Immunopathol., 2006, 28, 17.
7. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M.: "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases". J. Immunol., 1995,155, 1151.
8. Golghern Jones E., Powrite F. et al.: "Dtpletion of CD25+ regulatory cells Uncovers immune responses to shared murine tumor rejection antigens". Immunol., 2002, 32, 3267.
9. Somasundaram R., Jacob L., Swoboda R. et al.: "Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta". Cancer Res., 2002, 62, 5267.
10. Wolf A.M., Wolf D., Steurer M. et al.: "Increase of regulatory T cells in the peripheral blood of cancer patients". Clin. Cancer Res., 2003, 9, 606.
11. Gallimore A., Sakaguchi S.: "Regulation of tumour immunity by CD25+ T cells". Immunology, 2002, 107, 5.
12. Ichihara F, Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H.: "Increased populations of regulatory T cells in peripheral blood and tumor-iniltrating lymphocytes in patients with gastric and esophageal carcinomas". Clin. Carcinoma Res., 2003, 9, 4404.
13. Chen M.L., Pittet M.J., Gorelik L. et al.: "Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo". Proc. Natl. Acad Sci., 2005,102, 419.
14. Yan Z., Daoxin M.C., Yong Z. et al.: "The imbalance of Th17/Treg in patients with uterine cervical cancer". Clinica Chimica Acta, 2011, 412, 894.
15. Feng L.L., Wang X.: "Targ eting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy". Chin. Med. J., 2010, 123, 3334.
16. Kono K., Kawaida H., Takahashi A. et al.: "CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers". Cancer Immunol. Immunother., 2006, 55, 1064.
17. Sung K.L., Jee Y.K., Byung W.J. et al.: "Foxp3high and Foxp3low Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood". Hum. Immunol., 2011, 72, 621.
18. Hori S., Nomura T., Sakaguchi S.: "Control of regulatory T cell development by the transcription factor Foxp3". Science, 2003, 299, 1057.
19. Brunkow M.E., Jeffery E.W., Hjerrild K.A. et al.: "Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse". Nat. Genet., 2001, 27, 68.
20. Yagi H., Nomura T., Nakamura K. et al.: "Crucial role of FOXP3 in the development and function of human CD4+CD25+ reguzatory T cells". Int. Immunol., 2004, 16, 1643.
21. Chen W., J in W., Hardegen N. et al.: "Conversion of peripheral CD4 + CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3". J. Exp. Med., 2003, 198, 1875.
22. Ghiringhelli F., Puig P.E., Roux S. et al.: "Tumor cells convert immature myeloid dendritic cells into TGF-β secreting cells inducing CD4+CD25+ regulatory T cell proliferation". J. Exp. Med., 202, 919.
23. Lundqvist A., Palmborg A., Pavlenko M. et al.: "Mature dendritic cells induce tumor specific type 1 regulatory T cells". J. Immunother., 2005, 28, 229.
24. Ioppolo S., Notargiacomo S., Profumo E. et al.: "Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patients". Parasite Immunol., 1996, 18, 571.
25. Piccirillo C.A., Letterio J.J., Thornton A.M. et al.: "CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta 1 production and responsiveness". J. Exp. Med., 2002, 796, 237.
26. Fahlen L., Read S., Gorelik L. et al.: "T cells that cannot respond to TGF-{beta} escape control by CD4+CD25+ regulatory T cells". J. Exp. Med., 2005, 201, 737.